Sitafol MXR Slow Release Tablet 50/1000 mg

Adult dose

Take 1 tablet of this medication 100/1000 mg slow-release once daily. Patients taking this medication 50/500 mg slow-release or 50/1000 mg slow-release should take 2 tablets at the same time once daily. 1. For patients currently not treated with metformin: The initial dose of this medication is 100 mg of sitagliptin and 1000 mg of metformin per day in total. As an initial dose,

This medication is a drug used for the treatment of diabetes, containing two components. The first component helps to control blood sugar, but serious allergic reactions may occur in some patients, so caution is advised. If symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur within 3 months of taking the medication, discontinue use immediately and consult a physician. The second component lowers blood sugar but should not be administered to patients with poor kidney function or those experiencing severe infection or dehydration. Additionally, acute pancreatitis may develop, so if abdominal pain, vomiting, or severe abdominal discomfort occurs, immediately inform medical personnel. This medication should be taken with regular monitoring of kidney function, and if kidney function worsens rapidly or dehydration symptoms occur, use should be discontinued. Excessive alcohol consumption may increase the risk of side effects from this medication, so it is advisable to avoid alcohol. In situations such as surgery, severe infections, or trauma, the use of this medication should be temporarily suspended and resumed once the condition stabilizes. Additionally, this medication may cause hypoglycemia, so regular meals are important, and extra caution should be taken for hypoglycemic symptoms when taken with other blood sugar-lowering agents. It is advisable not to use this medication in pregnant or breastfeeding women or in children under 18 years of age, as safety has not been confirmed. Elderly patients may have a higher risk of decreased kidney function, therefore dosage adjustment and kidney function monitoring are necessary. During the use of this medication, it is important to routinely check blood sugar, kidney function, and conduct blood tests to monitor health status. If overdose is suspected, visit a hospital immediately for appropriate treatment; this medication can be partially removed through dialysis.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing (including anaphylaxis and severe acute hypersensitivity reactions), rash, dermatitis, Stevens-Johnson syndrome, severe skin adverse reactions, vesicular similar pemphigoid, acute pancreatitis (including fatal/non-fatal hemorrhagic or necrotizing pancreatitis), acute renal failure, liver dysfunction (possible increase in liver enzymes and jaundice), severe hypoglycemia (including altered consciousness and seizures), severe

Mild side effects

• Diarrhea
• upper respiratory tract infection
• headache
• nausea
• vomiting
• abdominal pain
• nasopharyngitis
• constipation
• muscle pain
• limb pain

This medication should be stored in a tightly closed container to protect it from air and moisture and should ideally be kept at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's efficacy and ensure safe usage.

Appearance

Bright green, oval-shaped slow-release film-coated tablet with a convex surface on both sides

Package unit

28 tablets/bottle, 56 tablets/bottle, 200 tablets/bottle